Zhengye Biotechnology

ZYBTNasdaq China Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$89.570 M

$1.89 -9.57%

Close of 7 Aug 2026

Revenue

$16.6M

#3061 by revenue

Earnings

-$9.98M

Loss-making

Shares outstanding

47,391,376

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#310Biomea FusionBMEA$91.3M
#311Neonc TechnologiesNTHI$90.8M
#312Zhengye BiotechnologyZYBT$89.6M
#313Fortress BiotechFBIO$88.7M
#314Verrica PharmaceuticalsVRCA$87.3M

Where these numbers come from

Share counts and financials for Zhengye Biotechnology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.